Category Archives : News

Home  >>  News

DKFZ: How oxytocin signals regulate behavior

On March 30, 2015, Posted by , In News,News Network Members, With No Comments

The neuropeptide oxytocin impacts the nervous system and, thus, regulates human behavior. Valery Grinevich, a researcher at the German Cancer Research Center (DKFZ), wants to uncover the molecular mechanisms underlying this regulation. To this end, Grinevich, who leads the Chica and Heinz Schaller Research Group “Neuropeptides” at the DKFZ, is…

DKFZ: Selective inhibition of a specific enzyme reduces side effects

On March 18, 2015, Posted by , In News,News Network Members, With No Comments

In cases of neuroblastoma, which is an aggressive type of cancer in children, tumor growth can be slowed down by selective inhibition of a specific cancer-promoting enzyme. Scientists from the German Cancer Research Center (DKFZ) have now shown in experiments that this leads to less aggressive growth of the cancer…

Biotech Financing: Affimed (Nasdaq: AFMD) rings The Nasdaq Stock Market Opening Bell

On February 10, 2015, Posted by , In News, With No Comments

The Heidelberg based clinical-stage immuno-oncology company Affimed N.V. went public on the Nasdaq in September 2014 and has raised USD 56 million in an IPO. Affimed shares are traded on the Nasdaq Global Market under the symbol AFMD. In honor of the occasion, Dr. Adi Hoess, CEO, rang the opening…